Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-25-112239

Options or other derivatives

  • Chief Executive Officer acquired 1,478,000 shares (grant or award)
  • Chief Executive Officer returned 1,478,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Moss David J Chief Executive Officer 2025-11-18 Returned to the company · Stock Option (right to buy) −400,000 0 D: show line 1 in the form
Moss David J Chief Executive Officer 2025-11-18 Grant or award · Stock Option (right to buy) +400,000 400,000 D: show line 2 in the form
Moss David J Chief Executive Officer 2025-11-18 Returned to the company · Stock Option (right to buy) −59,337 0 D: show line 3 in the form
Moss David J Chief Executive Officer 2025-11-18 Grant or award · Stock Option (right to buy) +59,337 59,337 D: show line 4 in the form
Moss David J Chief Executive Officer 2025-11-18 Returned to the company · Stock Option (right to buy) −275,000 0 D: show line 5 in the form
Moss David J Chief Executive Officer 2025-11-18 Grant or award · Stock Option (right to buy) +275,000 275,000 D: show line 6 in the form
Moss David J Chief Executive Officer 2025-11-18 Returned to the company · Stock Option (right to buy) −70,663 0 D: show line 7 in the form
Moss David J Chief Executive Officer 2025-11-18 Grant or award · Stock Option (right to buy) +70,663 70,663 D: show line 8 in the form
Loading xslF345X05/ownership.xml…